Clementia Pharmaceuticals Inc.
CMTA
CMTA was delisted on the 17th of April, 2019.
38 hedge funds and large institutions have $342M invested in Clementia Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
3% more funds holding
Funds holding: 37 → 38 (+1)
16% less capital invested
Capital invested by funds: $410M → $342M (-$67.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$10.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.2M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$3.72M |
| 4 |
AG
Artal Group
Luxembourg
|
+$3.25M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$11.1M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.69M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.32M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.14M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$949K |
CMTA Hedge Fund Activity: Q1 2018 in Review
38 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q1 2018, worth a combined $342M — down 16% from $410M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CMTA positions and 9 closed out — a net gain of 1 holder — while 14 added to existing stakes and 6 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $10.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $11.1M sold.
- 38 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q1 2018, up from 37 in Q4 2017.
- Funds reported $342M of Clementia Pharmaceuticals Inc. stock for Q1 2018, down 16% quarter-over-quarter.
- 10 funds opened new Clementia Pharmaceuticals Inc. positions in Q1 2018 and 9 closed out, a net change of +1 holder.
- The largest Clementia Pharmaceuticals Inc. buyer in Q1 2018 was Janus Henderson Group, an estimated $10.5M added.
- The largest Clementia Pharmaceuticals Inc. seller in Q1 2018 was RA Capital Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q1 2018.